Range
367.84 - 379.94
Vol / Avg.
93.9K/350.7K
Div / Yield
-
52 Wk
219.2 - 426.56
Mkt Cap
35.4B
Payout Ratio
-
Open
375.28
P/E
-
EPS
-5.2
Shares
93.3M
Outstanding
93.3M
Total Float
-
Benzinga - Sep 17, 2021, 2:17PM
Benzinga - Sep 14, 2021, 10:32AM
load more
Sector: Health Care.Industry: Biotechnology
BeiGene Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS-4.140-5.230 -1.0900
REV215.430M149.992M-65.438M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

BeiGene Questions & Anwsers

Q

How do I buy BeiGene (BGNE) stock?

A

You can purchase shares of BeiGene (NASDAQ: BGNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BeiGene's (BGNE) competitors?

Q

What is the target price for BeiGene (BGNE) stock?

A

The latest price target for BeiGene (NASDAQ: BGNE) was reported by SVB Leerink on October 14, 2021. The analyst firm set a price target for 414.00 expecting BGNE to rise to within 12 months (a possible 9.27% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BeiGene (BGNE)?

A

The stock price for BeiGene (NASDAQ: BGNE) is $378.88 last updated Fri Oct 22 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does BeiGene (BGNE) pay a dividend?

A

There are no upcoming dividends for BeiGene.

Q

When is BeiGene (NASDAQ:BGNE) reporting earnings?

A

BeiGene’s $Q3 earnings are confirmed for after-market on $November 4, 2021.

Q

Is BeiGene (BGNE) going to split?

A

There is no upcoming split for BeiGene.

Q

What sector and industry does BeiGene (BGNE) operate in?

A

BeiGene is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.